Target Name: RBMS3
NCBI ID: G27303
Review Report on RBMS3 Target / Biomarker Content of Review Report on RBMS3 Target / Biomarker
RBMS3
Other Name(s): RNA binding motif single stranded interacting protein 3 | RNA binding protein | RBMS3_HUMAN | RNA binding motif single stranded interacting protein 3, transcript variant 1 | RNA-binding protein | RNA binding motif, single stranded interacting protein | RNA-binding motif, single-stranded-interacting protein 3 (isoform 1) | RNA-binding motif, single-stranded-interacting protein 3 | DD23-L | RBMS3 variant 1

Understanding The Biology and Potential Applications of RBMS3

RNA binding motif single stranded interacting protein 3 (RBMS3) is a protein that plays a crucial role in regulating gene expression and has been linked to various diseases, including cancer. Despite its importance, RBMS3 is not well understood, and there are limited research studies available on its biology and potential as a drug target or biomarker. In this article, we will explore the biology and potential applications of RBMS3.

The RNA binding motif is a common protein-protein interaction that is found in various cellular processes, including DNA binding proteins, RNA binding proteins, and protein-protein interactions. RBMS3 is a member of the RBMS family, which includes other proteins that are involved in regulating gene expression, such as RBMS1 and RBMS2. These proteins share a conserved catalytic core and a specific interaction domain, which is responsible for their unique biological functions.

RBMS3 is a 21 kDa protein that was identified as a potential drug target in various studies. It is expressed in various tissues and cells, including brain, heart, and cancer cells. RBMS3 has been shown to play a role in cell signaling pathways, including cell proliferation, apoptosis, and autophagy.

One of the most significant functions of RBMS3 is its ability to interact with RNA molecules. This interaction is mediated by the protein's N-terminal domain, which contains a leucine-rich region (LRR) and a proline-rich region (PRR). The LRR and PRR are involved in the formation of a specific interaction domain, which allows RBMS3 to recognize specific RNA molecules.

In addition to its role in RNA recognition, RBMS3 is also involved in the regulation of gene expression. Several studies have shown that RBMS3 can interact with known RNA-binding proteins, including HDAS2, HDAS3, and RNA-protein interactions. This interaction allows RBMS3 to regulate the activity of these proteins, which in turn can affect gene expression.

Another potential application of RBMS3 is its use as a biomarker for cancer. Cancer is a disease that is characterized by the uncontrolled growth and spread of cells. The regulation of gene expression is a key aspect of cancer development, and RBMS3 is involved in this process . Therefore, RBMS3 has the potential to be used as a biomarker for cancer diagnosis and treatment.

In conclusion, RBMS3 is a protein that plays a crucial role in regulating gene expression and has been linked to various diseases, including cancer. Its unique RNA binding mechanism and involvement in cell signaling pathways make it an attractive drug target and biomarker. Further research is needed to fully understand the biology and potential applications of RBMS3, and to develop effective treatments for various diseases.

Protein Name: RNA Binding Motif Single Stranded Interacting Protein 3

Functions: Binds poly(A) and poly(U) oligoribonucleotides

The "RBMS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBMS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ | RBPJL | RBPJP2 | RBPMS | RBPMS-AS1 | RBPMS2 | RBSN | RBX1 | RC3H1 | RC3H2 | RCAN1 | RCAN2 | RCAN3 | RCAN3AS | RCBTB1 | RCBTB2 | RCC1 | RCC1L | RCC2 | RCCD1 | RCE1 | RCHY1 | RCL1 | RCN1 | RCN1P2 | RCN2 | RCN3 | RCOR1 | RCOR2 | RCOR3 | RCSD1 | RCVRN | RD3 | RD3L | RDH10 | RDH11 | RDH12 | RDH13 | RDH14 | RDH16 | RDH5 | RDH8 | RDM1 | RDUR | RDX | RDXP2 | Reactive oxygen species (ROS) | REC114 | REC8 | RECK | RECQL | RECQL4 | RECQL5 | REELD1 | REEP1 | REEP2 | REEP3 | REEP4 | REEP5 | REEP6 | REG1A | REG1B | REG1CP | REG3A | REG3G | REG4 | REL | REL-DT | RELA | Relaxin | Relaxin receptor | RELB | RELCH | RELL1 | RELL2 | RELN | RELT | REM1 | REM2 | REN